PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22859722-4 2012 Every P450 tested except CYP2E1 was capable of raloxifene bioactivation, based on glutathione adduct formation. Raloxifene Hydrochloride 47-57 cytochrome P450 family 2 subfamily B member 6 Homo sapiens 6-10 22859722-0 2012 Cytochrome p450 architecture and cysteine nucleophile placement impact raloxifene-mediated mechanism-based inactivation. Raloxifene Hydrochloride 71-81 cytochrome P450 family 2 subfamily B member 6 Homo sapiens 11-15 22859722-3 2012 Raloxifene, a drug known to undergo CYP3A-mediated reactive metabolite formation and time-dependent inhibition in vitro, was used to explore the potential for bioactivation and enzyme inactivation of additional P450 enzymes (CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A5). Raloxifene Hydrochloride 0-10 cytochrome P450 family 2 subfamily B member 6 Homo sapiens 211-215